Literature DB >> 22007631

N-alkenyl indoles as useful intermediates for alkaloid synthesis.

Hao Li1, Nawong Boonnak, Albert Padwa.   

Abstract

A mild cross-coupling reaction to access several N-alkenyl-substituted indoles has been developed. The coupling procedure involves treating a NH-indole with various alkenyl bromides using a combination of 10 mol % of copper(I) iodide and 20 mol % of ethylenediamine as the catalyst in dioxane at 110 °C in the presence of K(3)PO(4) as the base. When treated with acid, these unique enamines produce a dimeric product derived from a preferred protonation reaction at the enamine π-bond. A cationic cyclization reaction of the readily available 2-(2-(1H-indol-1-yl)allyl)cyclopentanol was utilized to construct tetracyclic indole derivatives with a quaternary stereocenter attached to the C(2)-position of the indole ring. An alternative strategy for selective functionalization at the C(2)-position of a N-alkenyl-substituted indole derivative that was also studied involves a radical cyclization of a xanthate derivative. The work described provides an attractive route to the tetracyclic core of some vinca alkaloids, including the tetrahydroisoquinocarbazole RS-2135.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007631     DOI: 10.1021/jo201955c

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Catalytic Cycloisomerization onto a Carbonyl Oxygen.

Authors:  Shicheng Shi; Jonathan L Kuo; Tao Chen; Jack R Norton
Journal:  Org Lett       Date:  2020-07-22       Impact factor: 6.005

2.  Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles.

Authors:  John T Gupton; Nakul Telang; Dominic F Gazzo; Peter J Barelli; Kristin E Lescalleet; Jonathan W Fagan; Brandon J Mills; Kara L Finzel; Rene P F Kanters; Kyle R Crocker; Sean T Dudek; Corinne M Lariviere; Stanton Q Smith; Kartik M Keertikar
Journal:  Tetrahedron       Date:  2013-07-22       Impact factor: 2.457

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.